Xiamen Sinopeg Biotech Co., Ltd. is a prominent supplier in the pharmaceutical industry, specialising in drug delivery systems and related medical device businesses. The company is committed to the research, development, production, and sales of high-end drug delivery carriers, auxiliary materials, and active pharmaceutical ingredients (APIs). Their extensive product portfolio includes polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, and viral-like particles. These products are crucial in the formulation of long-acting protein and peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control medications, macromolecular micelle drugs, liposome drugs, gene therapy treatments, immunosuppressants, ADC drugs, ProTAC drugs, and medical hydrogels, positioning the company as a leader in the industry.

Services include:
- Intermediates
- Fine Chemicals
- CDMO services
- Solution services

SINOPEG XIAMEN SINOPEG BIOTECH CO. continually advances its capabilities in drug delivery systems while ensuring their offerings meet the high standards of the pharmaceutical sector. For further information, please visit sinopeg.com.